Anti-Hu CD25 Purified

• Clone:

  MEM-140

• Format:

  Purified

• Buffer:

  Tris buffered saline (TBS), pH 8.0, 15 mM sodium azide

• Other References:

  *Sotlar K, Horny HP, Simonitsch I, Krokowski M, Aichberger KJ, Mayerhofer M, Printz D, Fritsch G, Valent P: CD25 indicates the neoplastic phenotype of mast cells: a novel immunohistochemical marker for the diagnosis of systemic mastocytosis (SM) in routinely processed bone marrow biopsy specimens. Am J Surg Pathol. 2004 Oct;28 (10) :1319-25., URL: https://www.ncbi.nlm.nih.gov/pubmed/15371947?ordin, *Morris JC, Waldmann TA: Advances in interleukin 2 receptor targeted treatment. Ann Rheum Dis. 2000 Nov;59 Suppl 1:i109-14., URL: https://www.ncbi.nlm.nih.gov/pubmed/11053100?ordin, *Scheibenbogen C, Keilholz U, Richter M, Andreesen R, Hunstein W: The interleukin-2 receptor in human monocytes and macrophages: regulation of expression and release of the alpha and beta chains (p55 and p75) . Res Immunol. 1992 Jan;143 (1) :33-7., URL: https://www.ncbi.nlm.nih.gov/pubmed/1565844?ordina, *Lai KN, Leung JC, Lai FM: Soluble interleukin 2 receptor release, interleukin 2 production, and interleukin 2 receptor expression in activated T-lymphocytes in vitro. Pathology. 1991 Jul;23 (3) :224-8., URL: https://www.ncbi.nlm.nih.gov/pubmed/1838146?ordina